1,973 results match your criteria: "Citizens Hospital[Affiliation]"

Interictal head-turning sign in patients with idiopathic generalized epilepsy during initial medical interview: A matched multicenter study.

Epilepsy Behav

November 2024

Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan; Epilepsy Center, Hiroshima University Hospital, Japan.

Article Synopsis
  • The study focused on the "head-turning sign," a behavioral marker potentially linked to idiopathic generalized epilepsy (IGE), comparing its prevalence in various patient groups.
  • Out of 579 patients analyzed, the head-turning sign was significantly more common in those with IGE (20.4%) than in non-IGE (2.2%) and non-epileptic patients (8.3%).
  • Key factors associated with the sign included the diagnosis of IGE, presence of myoclonic seizures, visits by a parent, and comorbid headaches, suggesting the sign's potential as a diagnostic tool for IGE.
View Article and Find Full Text PDF
Article Synopsis
  • - In the CAPItello-291 study, capivasertib combined with fulvestrant showed improved progression-free survival (PFS) compared to placebo in patients with advanced HR-positive/HER2-negative breast cancer, including those with specific genetic alterations (PIK3CA, AKT1, or PTEN).
  • - Among the 708 total patients, 78 were from Japan, where results also indicated a numerical PFS benefit for the capivasertib-fulvestrant group, suggesting consistency with global findings.
  • - The safety profile for the Japanese subgroup was similar to that of the worldwide population, indicating no new safety concerns, thus supporting the efficacy of the treatment approach.
View Article and Find Full Text PDF
Article Synopsis
  • Long-term effectiveness and safety of omalizumab for Chronic Inducible Urticaria (CIndU) were evaluated in a large cohort across 14 specialized centers, revealing it to be highly effective for most patients.
  • Out of 234 patients, 73% reported significant improvements while the median treatment duration exceeded 5 years, mainly due to disease control.
  • Patient age was a predictor of treatment continuation, with older patients less likely to discontinue due to well-controlled disease, and CIndU subtype did not impact treatment response or duration.
View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the effectiveness and safety of adding adjuvant S-1 chemotherapy after surgery in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who previously received neoadjuvant chemotherapy followed by surgery (NAC-S).
  • - A total of 52 patients participated, with a reported 3-year relapse-free survival rate of 72.3% and overall survival rate of 85.0%, indicating successful outcomes for the primary endpoint.
  • - The treatment had some side effects, with the most common grade ≥3 adverse events being neutropenia, anorexia, and diarrhea; however, no treatment-related deaths occurred, suggesting it is a safe option worth exploring further.
View Article and Find Full Text PDF
Article Synopsis
  • Multi-locus imprinting disturbance (MLID) affects methylation in certain genes and has been identified in about 150 cases of imprinting disorders, with inadequate previous research on this condition aside from one study on specific syndromes.
  • In a study of 783 patients, 29 individuals with confirmed epimutations displayed MLID, found in 12% of those with Beckwith-Wiedemann syndrome (BWS) and 5% with Silver-Russell syndrome (SRS), but not in other syndromes.
  • Further analysis revealed abnormal methylation patterns and deleterious genetic variants in mothers of MLID patients, with around 50% of MLID patients experiencing neurodevelopmental delays or intellectual disorders, indicating
View Article and Find Full Text PDF

Diagnostic performance of TILs-US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer.

Int J Clin Oncol

December 2024

Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3-Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.

Background: Tumor-infiltrating lymphocytes-ultrasonography (TILs-US) score is used to predict lymphocyte-predominant breast cancer (LPBC) in surgical specimens. We aimed to compare diagnostic performance of TILs-US score for predicting pathological complete response (pCR) with that of LPBC in biopsy specimens.

Methods: TILs ≥ 50% in biopsy specimens was defined as biopsy-LPBC, and TILs-US score ≥ 4 was categorized as TILs-US score-high.

View Article and Find Full Text PDF

Background: Because of the increasing prevalence of dementia in Japan, the government introduced financial incentives for specialized care for dementia at acute care hospitals in 2016. Our hospital then introduced a multidisciplinary collaborative specialized team, referred to as dementia-specialized care team. The aim of this study is to examine the influence of dementia-specialized care team on clinical outcomes for elderly inpatients.

View Article and Find Full Text PDF

Thoracic endovascular aortic repair (TEVAR) for thoracic aortic aneurysms (TAAs) is an alternative treatment option for high-risk patients. While conventionally performed via a transfemoral approach, it is sometimes difficult due to poor access routes. We report the case of a 90-year-old man who was incidentally diagnosed with a descending TAA while undergoing computed tomography for esophageal cancer.

View Article and Find Full Text PDF
Article Synopsis
  • Severe acute cholecystitis (AC) is a serious condition that can cause systemic infections and organ dysfunction, prompting a study on the best timing and effectiveness of surgery and pre-operative drainage methods.
  • The research involved 142 patients who were divided into early cholecystectomy (EC) within 72 hours of symptoms and delayed cholecystectomy (DC), along with their surgical outcomes compared.
  • Findings showed that patients eligible for EC had better surgical results, while preoperative percutaneous cholecystostomy (PC) reduced intraoperative bleeding and hospital stays but was linked to higher rates of complications in those with cardiovascular issues or taking warfarin.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined whether a standard dose of bilastine (20 mg) is as effective as a double dose of second-generation H1-antihistamines for treating patients with refractory chronic spontaneous urticaria (CSU).
  • Conducted as a phase IV, multicenter trial, it involved 128 patients and measured treatment efficacy through the mean total symptom score (TSS) after 5-7 days of administration.
  • Results showed that bilastine was non-inferior in effectiveness to double-dose H1AH and had a similar safety profile, with no serious adverse effects reported in either treatment group.
View Article and Find Full Text PDF

A case of chronic spontaneous urticaria with wheals lasting for more than a week.

J Dermatol

September 2024

Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Article Synopsis
  • Urticaria is a skin condition where raised bumps (wheals) appear and usually go away within a day or two.
  • A 58-year-old man experienced itchy, red, ring-shaped spots for about two months, which got bigger but then disappeared after several days.
  • After trying different medications without improvement, he finally felt better after taking a steroid and another medication, and the rash didn’t come back after stopping all treatments.
View Article and Find Full Text PDF
Article Synopsis
  • * A study involving 237 patients showed that 30% developed prosthesis-patient mismatch (PPM), with higher MPV levels in those with PPM and less reduction in MPV post-surgery compared to those without PPM.
  • * MPV at the six-month follow-up can help predict PPM in AS patients after TAVR, indicating it may be useful for monitoring during recovery.
View Article and Find Full Text PDF
Article Synopsis
  • Hepatic portal venous gas is a rare condition linked to severe bowel issues like ischemic colitis or cancer, as illustrated by a case involving a 72-year-old man with ileocecal cancer and sepsis from Klebsiella pneumoniae.
  • The patient was admitted for diabetes control but developed fever and septic shock without typical abdominal symptoms; imaging revealed gas in the portal vein, indicating a serious underlying infection.
  • Early detection through abdominal ultrasound was crucial, highlighting that hepatic portal venous gas should prompt urgent investigation to address potential infections or complications from underlying conditions.
View Article and Find Full Text PDF
Article Synopsis
  • In Japan, a study was conducted on the safety and efficacy of ligelizumab, an anti-IgE monoclonal antibody, for treating chronic spontaneous urticaria (CSU) in patients who weren't responding well to H1-antihistamines.
  • The study, which included 66 adult participants, showed that while 80.3% experienced mild to moderate side effects, there were no severe adverse events or anaphylaxis, and only 6.1% stopped treatment due to side effects.
  • Significant improvements were noted: UAS7 scores improved quickly by Week 4 and continued to improve by Week 52, with 50% of patients achieving no symptoms, and a notable increase in quality of life
View Article and Find Full Text PDF

Background: Hepatocellular carcinoma (HCC) ranks third in cancer-related deaths globally. Despite treatment advances, high post-hepatectomy recurrence rates (RR), especially with liver fibrosis and hepatitis C virus infection, remain challenging. Key prognostic factors include vascular invasion and perioperative blood loss, impacting extrahepatic recurrence.

View Article and Find Full Text PDF

We report the case of a 51-year-old Japanese man with chronic myeloid leukemia (CML) initially diagnosed in the chronic phase. For 16 years, the patient maintained chronic phase (CP) under treatment with first- and second-generation tyrosine kinase inhibitors (TKIs), including imatinib, dasatinib, and bosutinib, none of which resulted in ABL1 mutations. However, despite long-term disease stability, the patient experienced an abrupt progression to the megakaryocytic blast phase (MBP), a rare and aggressive form of CML.

View Article and Find Full Text PDF

Patients with esophageal cancer who have severe complications such as diabetes sometimes require two-stage surgery. Herein, we describe two cases of gastric emphysema that were treated at our facility after the patients had previously undergone minimally invasive esophagectomy as the first-stage surgical treatment of esophageal cancer. Case 1: A 72-year-old man with a history of diabetes mellitus (DM) was diagnosed with esophageal cancer and an esophageal obstruction and subsequently underwent percutaneous endoscopic gastrostomy (PEG) placement followed by neoadjuvant chemoradiotherapy.

View Article and Find Full Text PDF

Background: A head-to-head comparison between enzalutamide (ENZ) and abiraterone plus prednisolone (ABI) revealed similar survival benefits for castration-resistant prostate cancer (CRPC) in the ENABLE study for PCa. Considering that a dose reduction of ENZ and ABI has demonstrated sufficient inhibitory ability of androgen receptor (AR) signaling, we analyzed the efficacy of modified doses of these agents in the ENABLE study for PCa.

Methods: This investigator-initiated, multicenter, randomized controlled trial that was conducted in Japan analyzed the prespecified survival endpoints, prostate-specific antigen (PSA) response rate ( ≥50% decline from baseline), and safety profile in patients treated with modified doses (ENZ ≤ 120 mg/day, ABI ≤ 750 mg/day) compared with those treated with a standard dose (ENZ 160 mg/day, ABI 1000 mg/day) as a starting dose.

View Article and Find Full Text PDF

Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022. Recently, the European Society of Cardiology (ESC) published the guidelines for the management of acute coronary syndrome in 2023.

View Article and Find Full Text PDF

Background: The minimum diameter of the patent ductus arteriosus measured in the lateral angiographic view is usually used to determine the device size. Sometimes the device can be easily removed from the patent ductus arteriosus, even if it appears to be the optimum size.

Methods: From 2016 to 2021, 29 patients who underwent contrast-enhanced CT prior to patent ductus arteriosus closure included.

View Article and Find Full Text PDF

Background: Minimally invasive thoracic surgical techniques require effective lung isolation using one-lung ventilation (OLV). Verification of lung isolation may be confirmed by auscultation, visual confirmation using fiberoptic bronchoscopy (FOB), or more recently, point-of-care ultrasound (POCUS). The aim of this study was to prospectively compare lung ultrasound with clinical auscultation to confirm OLV before thoracic surgery in pediatric patients.

View Article and Find Full Text PDF
Article Synopsis
  • Hereditary angioedema (HAE) significantly impacts patients' quality of life, and understanding the disease burden is crucial for effective treatment.
  • In 2021, patient-reported outcome measures (PROMs) showed that higher attack frequencies correlated with increased health-related quality of life (HRQoL) impairment.
  • The study highlighted that patients experiencing more frequent HAE attacks had notable difficulties in work productivity, experiencing both absenteeism and presenteeism.
View Article and Find Full Text PDF

Glutamic acid decarboxylase (GAD) antibodies are frequently measured in diabetes care as islet-associated autoantibodies that are useful in the diagnosis of type 1 diabetes. However, GAD antibodies derived from other persons may contaminate immunoglobulin preparations, and there have been cases of transiently positive GAD antibodies after intravenous immunoglobulin (IVIg) in patients who were originally negative for GAD antibodies. Clinicians may be unaware of such contamination and misdiagnose some cases as type 1 instead of type 2 diabetes mellitus based on positivity for GAD antibodies.

View Article and Find Full Text PDF